Price T Rowe Associates Inc Xencor Inc Transaction History

Price T Rowe Associates Inc

$836 Billion
Q2 2024

A detailed history of Price T Rowe Associates Inc transactions in Xencor Inc stock. As of the latest transaction made, Price T Rowe Associates Inc holds 3,962,403 shares of XNCR stock, worth $89.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

3,962,403

Previous 3,819,656 3.74%

Holding current value

$89.9 Million

Previous $84.5 Million 11.26%

% of portfolio

0.01%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$18.21 - $24.5 $2.6 Million - $3.5 Million	142,747 Added 3.74%	3,962,403 $75 Million
Q1 2024 May 15, 2024	BUY	$18.65 - $26.52 $6.26 Million - $8.91 Million	335,881 Added 9.64%	3,819,656 $84.5 Million
Q4 2023 Feb 14, 2024	BUY	$16.53 - $21.42 $4.94 Million - $6.4 Million	298,841 Added 9.38%	3,483,775 $74 Million
Q3 2023 Nov 14, 2023	BUY	$20.08 - $25.39 $529,268 - $669,229	26,358 Added 0.83%	3,184,934 $64.2 Million
Q2 2023 Aug 14, 2023	SELL	$24.77 - $29.9 $3.23 Million - $3.9 Million	-130,313 Reduced 3.96%	3,158,576 $78.9 Million
Q1 2023 May 15, 2023	BUY	$25.95 - $36.95 $1.82 Million - $2.59 Million	70,128 Added 2.18%	3,288,889 $91.7 Million
Q4 2022 Feb 14, 2023	BUY	$24.79 - $30.86 $226,828 - $282,369	9,150 Added 0.29%	3,218,761 $83.8 Million
Q3 2022 Nov 14, 2022	SELL	$24.62 - $32.44 $83.4 Million - $110 Million	-3,389,460 Reduced 51.36%	3,209,611 $83.4 Million
Q2 2022 Aug 15, 2022	BUY	$19.74 - $29.01 $14.7 Million - $21.6 Million	744,569 Added 12.72%	6,599,071 $181 Million
Q1 2022 May 16, 2022	SELL	$26.68 - $41.63 $1.45 Million - $2.26 Million	-54,181 Reduced 0.92%	5,854,502 $156 Million
Q4 2021 Feb 14, 2022	SELL	$33.67 - $43.44 $790,908 - $1.02 Million	-23,490 Reduced 0.4%	5,908,683 $237 Million
Q3 2021 Nov 15, 2021	BUY	$30.65 - $35.68 $2.09 Million - $2.44 Million	68,264 Added 1.16%	5,932,173 $194 Million
Q2 2021 Aug 16, 2021	BUY	$34.33 - $44.68 $5.64 Million - $7.34 Million	164,248 Added 2.88%	5,863,909 $202 Million
Q1 2021 May 17, 2021	BUY	$40.81 - $53.88 $379,737 - $501,353	9,305 Added 0.16%	5,699,661 $245 Million
Q4 2020 Feb 16, 2021	BUY	$36.63 - $47.63 $208 Million - $271 Million	5,690,356 New	5,690,356 $248 Million

Others Institutions Holding XNCR

# of Institutions

202

Shares Held

63.2M

Call Options Held

3.9K

Put Options Held

View Full List

About Xencor Inc

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $1.35B
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

More about XNCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Xencor Inc Transaction History